Last 12 months
Inside the activity.
0 purchase rows · 49 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 13 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 12 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2026 Filed Mar 3, 2026 23:45 UTC |
Russell Steven JonChief Medical Officer
|
GrantCommon Stock | 109,105 | $0.00 | $0.00 |
DisclosureSEC source: 0002051384-26-000001 · form4-03032026_060308.xml · nonDerivative · entry 1 Russell Steven Jon · CIK 0002051384 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,122 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:45 UTC |
Hopman MarkChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 58,749 | $0.00 Strike: $12.63 | $0.00 |
DisclosureSEC source: 0002048497-26-000001 · form4-03032026_060310.xml · derivative · entry 3 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,749 Underlying: Common Stock · 58,749 shares Expires 2036-02-26 F4 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:45 UTC |
Hopman MarkChief Commercial Officer
|
GrantCommon Stock | 109,105 | $0.00 | $0.00 |
DisclosureSEC source: 0002048497-26-000001 · form4-03032026_060310.xml · nonDerivative · entry 1 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,320 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:45 UTC |
Mensinger MikeChief Product Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 58,749 | $0.00 Strike: $12.63 | $0.00 |
DisclosureSEC source: 0002048500-26-000004 · form4-03032026_060306.xml · derivative · entry 3 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,749 Underlying: Common Stock · 58,749 shares Expires 2036-02-26 F4 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:45 UTC |
Mensinger MikeChief Product Officer
|
GrantCommon Stock | 109,105 | $0.00 | $0.00 |
DisclosureSEC source: 0002048500-26-000004 · form4-03032026_060306.xml · nonDerivative · entry 1 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,857 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:45 UTC |
Feider StephenChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 70,831 | $0.00 Strike: $12.63 | $0.00 |
DisclosureSEC source: 0002048588-26-000003 · form4-03032026_060304.xml · derivative · entry 3 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,831 Underlying: Common Stock · 70,831 shares Expires 2036-02-26 F4 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:45 UTC |
Feider StephenChief Financial Officer
|
GrantCommon Stock | 131,543 | $0.00 | $0.00 |
DisclosureSEC source: 0002048588-26-000003 · form4-03032026_060304.xml · nonDerivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,157 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:45 UTC |
Saint SeanDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 184,837 | $0.00 Strike: $12.63 | $0.00 |
DisclosureSEC source: 0002048593-26-000001 · form4-03032026_060302.xml · derivative · entry 3 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,837 Underlying: Common Stock · 184,837 shares Expires 2036-02-26 F4 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026. Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 23:45 UTC |
Saint SeanDirector · President & CEO
|
GrantCommon Stock | 343,269 | $0.00 | $0.00 |
DisclosureSEC source: 0002048593-26-000001 · form4-03032026_060302.xml · nonDerivative · entry 1 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,193 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| February 27, 2026 Filed Mar 13, 2026 20:15 UTC Amendment |
Russell Steven JonChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 91,520 | $0.00 Strike: $12.63 | $0.00 |
DisclosureSEC source: 0002051384-26-000002 · form4a-03132026_040312.xml · derivative · entry 1 Russell Steven Jon · CIK 0002051384 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,520 Underlying: Common Stock · 91,520 shares Expires 2036-02-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026. Read SEC document |
| February 27, 2026 Filed Mar 13, 2026 20:15 UTC Amendment |
Mensinger MikeChief Product Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 91,520 | $0.00 Strike: $12.63 | $0.00 |
DisclosureSEC source: 0002048500-26-000006 · form4a-03132026_040314.xml · derivative · entry 1 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,520 Underlying: Common Stock · 91,520 shares Expires 2036-02-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026. Read SEC document |
| February 27, 2026 Filed Mar 13, 2026 20:15 UTC Amendment |
Saint SeanDirector · President & CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 287,944 | $0.00 Strike: $12.63 | $0.00 |
DisclosureSEC source: 0002048593-26-000003 · form4a-03132026_040309.xml · derivative · entry 1 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,944 Underlying: Common Stock · 287,944 shares Expires 2036-02-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026. Read SEC document |
| February 27, 2026 Filed Mar 13, 2026 20:15 UTC Amendment |
Feider StephenChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 110,342 | $0.00 Strike: $12.63 | $0.00 |
DisclosureSEC source: 0002048588-26-000005 · form4a-03132026_040304.xml · derivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,342 Underlying: Common Stock · 110,342 shares Expires 2036-02-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026. Read SEC document |
| February 27, 2026 Filed Mar 13, 2026 20:15 UTC Amendment |
Hopman MarkChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 91,520 | $0.00 Strike: $12.63 | $0.00 |
DisclosureSEC source: 0002048497-26-000003 · form4a-03132026_040307.xml · derivative · entry 1 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,520 Underlying: Common Stock · 91,520 shares Expires 2036-02-26 F1 · derivative.exercise_date: The shares subject to this option shall vest in 36 equal monthly installments measured from March 1, 2026. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 01:30 UTC |
Palasis MariaDirector
|
GrantCommon Stock | 3,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001810701-26-000002 · form4-01142026_080107.xml · nonDerivative · entry 1 Palasis Maria · CIK 0001810701 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,432 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 01:30 UTC |
CARNEY SEANDirector
|
GrantCommon Stock | 3,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001239312-26-000002 · form4-01142026_080108.xml · nonDerivative · entry 1 CARNEY SEAN · CIK 0001239312 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,244 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 01:30 UTC |
MICHEL GERARD JDirector
|
GrantCommon Stock | 3,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001235644-26-000002 · form4-01142026_080110.xml · nonDerivative · entry 1 MICHEL GERARD J · CIK 0001235644 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,544 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 01:30 UTC |
Jones ChristyDirector
|
GrantCommon Stock | 3,997 | $0.00 | $0.00 |
DisclosureSEC source: 0002048467-26-000002 · form4-01142026_080105.xml · nonDerivative · entry 1 Jones Christy · CIK 0002048467 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,244 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 01:30 UTC |
Lezack AdamDirector
|
GrantCommon Stock | 3,997 | $0.00 | $0.00 |
DisclosureSEC source: 0002048466-26-000002 · form4-01142026_080103.xml · nonDerivative · entry 1 Lezack Adam · CIK 0002048466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,432 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| January 13, 2026 Filed Jan 15, 2026 01:30 UTC |
Dearen Danny L.Director
|
GrantCommon Stock | 3,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001756438-26-000002 · form4-01142026_080101.xml · nonDerivative · entry 1 Dearen Danny L. · CIK 0001756438 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,244 F1 · shares: Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan. Read SEC document |
| January 06, 2026 Filed Jan 7, 2026 21:16 UTC |
Mensinger MikeChief Product Officer
|
SaleCommon Stock | 2,200 | $30.10 | $66,221.10 |
DisclosureSEC source: 0002048500-26-000003 · form4-01072026_090132.xml · nonDerivative · entry 1 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,752 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025. F2 · price: The weighted average sale price for the transaction reported was $30.1005 and the range of prices were between $30.00 and $30.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 23:05 UTC |
Mensinger MikeChief Product Officer
|
SaleCommon Stock | 600 | $30.20 | $18,118.14 |
DisclosureSEC source: 0002048500-26-000002 · form4-01052026_110121.xml · nonDerivative · entry 2 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,952 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025. F3 · price: The weighted average sale price for the transaction reported was $30.1969 and the range of prices were between $30.10 and $30.52. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 23:05 UTC |
Mensinger MikeChief Product Officer
|
SaleCommon Stock | 7,200 | $29.56 | $212,832.00 |
DisclosureSEC source: 0002048500-26-000002 · form4-01052026_110121.xml · nonDerivative · entry 1 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,552 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025. F2 · price: The weighted average sale price for the transaction reported was $29.56 and the range of prices were between $29.05 and $30.02. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 23:03 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0002048588-26-000002 · form4-01052026_110150.xml · derivative · entry 3 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,695 Underlying: Common Stock · 20,000 shares Expires 2033-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 23:03 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 20,000 | $29.53 | $590,680.00 |
DisclosureSEC source: 0002048588-26-000002 · form4-01052026_110150.xml · nonDerivative · entry 2 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,614 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025. F2 · price: The weighted average sale price for the transaction reported was $29.534002 and the range of prices were between $29.09 and $30.06. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 23:03 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 20,000 | $5.10 | $102,000.00 |
DisclosureSEC source: 0002048588-26-000002 · form4-01052026_110150.xml · nonDerivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,614 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2025 Filed Mar 16, 2026 23:55 UTC |
Hopman MarkChief Commercial Officer
|
SaleCommon Stock | 2,061 | $30.66 | $63,192.32 |
DisclosureSEC source: 0002048497-26-000004 · form4-03162026_070303.xml · nonDerivative · entry 2 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 136,216 F2 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025. F3 · price: The weighted average sale price for the transaction reported was $30.6610 and the range of prices were between $30.02 and $31.0024. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:20 UTC |
Mensinger MikeChief Product Officer
|
SaleCommon Stock | 1,063 | $29.34 | $31,184.06 |
DisclosureSEC source: 0002048500-25-000004 · form4-12042025_041205.xml · nonDerivative · entry 1 Mensinger Mike · CIK 0002048500 · Chief Product Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,752 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:20 UTC |
Saint SeanDirector · President & CEO
|
SaleCommon Stock | 3,278 | $29.34 | $96,163.08 |
DisclosureSEC source: 0002048593-25-000005 · form4-12042025_041201.xml · nonDerivative · entry 1 Saint Sean · CIK 0002048593 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,924 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| December 02, 2025 Filed Dec 4, 2025 21:20 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 1,427 | $29.34 | $41,862.33 |
DisclosureSEC source: 0002048588-25-000008 · form4-12042025_041203.xml · nonDerivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,614 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| December 02, 2025 Filed Mar 16, 2026 23:55 UTC |
Russell Steven JonChief Medical Officer
|
SaleCommon Stock | 1,025 | $29.34 | $30,069.30 |
DisclosureSEC source: 0002051384-26-000003 · form4-03162026_070301.xml · nonDerivative · entry 1 Russell Steven Jon · CIK 0002051384 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 178,071 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| December 02, 2025 Filed Mar 16, 2026 23:55 UTC |
Hopman MarkChief Commercial Officer
|
SaleCommon Stock | 856 | $29.34 | $25,111.53 |
DisclosureSEC source: 0002048497-26-000004 · form4-03162026_070303.xml · nonDerivative · entry 1 Hopman Mark · CIK 0002048497 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,277 F1 · kind: The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:20 UTC |
Palasis MariaDirector
|
SaleCommon Stock | 500 | $29.96 | $14,982.00 |
DisclosureSEC source: 0001810701-25-000007 · form4-12022025_041202.xml · nonDerivative · entry 2 Palasis Maria · CIK 0001810701 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,435 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025. F3 · price: The weighted average sale price for the transaction reported was $29.9640 and the range of prices were between $29.80 and $30.23. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:20 UTC |
Palasis MariaDirector
|
SaleCommon Stock | 906 | $29.33 | $26,570.17 |
DisclosureSEC source: 0001810701-25-000007 · form4-12022025_041202.xml · nonDerivative · entry 1 Palasis Maria · CIK 0001810701 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,935 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025. F2 · price: The weighted average sale price for the transaction reported was $29.3269 and the range of prices were between $28.75 and $29.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:20 UTC |
Lezack AdamDirector
|
SaleCommon Stock | 500 | $29.91 | $14,955.00 |
DisclosureSEC source: 0002048466-25-000005 · form4-12022025_041204.xml · nonDerivative · entry 2 Lezack Adam · CIK 0002048466 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,435 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025. F3 · price: The weighted average sale price for the transaction reported was $29.91 and the range of prices were between $29.80 and $30.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 21:20 UTC |
Lezack AdamDirector
|
SaleCommon Stock | 906 | $29.35 | $26,587.75 |
DisclosureSEC source: 0002048466-25-000005 · form4-12022025_041204.xml · nonDerivative · entry 1 Lezack Adam · CIK 0002048466 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,935 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025. F2 · price: The weighted average sale price for the transaction reported was $29.3463 and the range of prices were between $28.75 and $29.63. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 31, 2025 Filed Nov 6, 2025 02:45 UTC |
Palasis MariaDirector
|
SaleCommon Stock | 119 | $27.45 | $3,266.57 |
DisclosureSEC source: 0001810701-25-000005 · form4-11052025_091101.xml · nonDerivative · entry 2 Palasis Maria · CIK 0001810701 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,841 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025. F3 · price: The weighted average sale price for the transaction reported was $27.4502 and the range of prices were between $27.32 and $27.57. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 31, 2025 Filed Nov 6, 2025 02:45 UTC |
Palasis MariaDirector
|
SaleCommon Stock | 1,287 | $26.86 | $34,567.28 |
DisclosureSEC source: 0001810701-25-000005 · form4-11052025_091101.xml · nonDerivative · entry 1 Palasis Maria · CIK 0001810701 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,960 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025. F2 · price: The weighted average sale price for the transaction reported was $26.8588 and the range of prices were between $26.27 and $27.22. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 31, 2025 Filed Nov 6, 2025 02:45 UTC |
Lezack AdamDirector
|
SaleCommon Stock | 38 | $27.70 | $1,052.60 |
DisclosureSEC source: 0002048466-25-000003 · form4-11052025_091104.xml · nonDerivative · entry 2 Lezack Adam · CIK 0002048466 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,841 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025. Read SEC document |
| October 31, 2025 Filed Nov 6, 2025 02:45 UTC |
Lezack AdamDirector
|
SaleCommon Stock | 1,368 | $26.85 | $36,727.24 |
DisclosureSEC source: 0002048466-25-000003 · form4-11052025_091104.xml · nonDerivative · entry 1 Lezack Adam · CIK 0002048466 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,879 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025. F2 · price: The weighted average sale price for the transaction reported was $26.8474 and the range of prices were between $26.27 and $27.24. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 03, 2025 Filed Oct 7, 2025 20:15 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,982 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0002048588-25-000004 · form4-10072025_041001.xml · derivative · entry 4 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,695 Underlying: Common Stock · 4,982 shares Expires 2033-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. Read SEC document |
| October 03, 2025 Filed Oct 7, 2025 20:15 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 1,154 | $22.28 | $25,708.58 |
DisclosureSEC source: 0002048588-25-000004 · form4-10072025_041001.xml · nonDerivative · entry 3 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,041 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025. F3 · price: The weighted average sale price for the transaction reported was $22.2778 and the range of prices were between $22.0438 and $22..47. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 03, 2025 Filed Oct 7, 2025 20:15 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 3,828 | $21.52 | $82,367.84 |
DisclosureSEC source: 0002048588-25-000004 · form4-10072025_041001.xml · nonDerivative · entry 2 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,195 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025. F2 · price: The weighted average sale price for the transaction reported was $21.5172 and the range of prices were between $21.04 and $22.0144. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 03, 2025 Filed Oct 7, 2025 20:15 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 4,982 | $5.10 | $25,408.20 |
DisclosureSEC source: 0002048588-25-000004 · form4-10072025_041001.xml · nonDerivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:31 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,018 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0002048588-25-000003 · form4-10032025_081044.xml · derivative · entry 4 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,677 Underlying: Common Stock · 15,018 shares Expires 2033-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:31 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 100 | $21.08 | $2,108.00 |
DisclosureSEC source: 0002048588-25-000003 · form4-10032025_081044.xml · nonDerivative · entry 3 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,041 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:31 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 14,918 | $20.76 | $309,697.68 |
DisclosureSEC source: 0002048588-25-000003 · form4-10032025_081044.xml · nonDerivative · entry 2 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,141 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025. F2 · price: The weighted average sale price for the transaction reported was $20.76 and the range of prices were between $20.03 and $21.03. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:31 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionCommon Stock | 15,018 | $5.10 | $76,591.80 |
DisclosureSEC source: 0002048588-25-000003 · form4-10032025_081044.xml · nonDerivative · entry 1 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 08, 2025 Filed Sep 9, 2025 20:12 UTC |
Feider StephenChief Financial Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,900 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001415889-25-023969 · form4-09092025_080923.xml · derivative · entry 3 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,695 Underlying: Common Stock · 9,900 shares Expires 2033-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023. Read SEC document |
| September 08, 2025 Filed Sep 9, 2025 20:12 UTC |
Feider StephenChief Financial Officer
|
SaleCommon Stock | 9,900 | $21.13 | $209,151.36 |
DisclosureSEC source: 0001415889-25-023969 · form4-09092025_080923.xml · nonDerivative · entry 2 Feider Stephen · CIK 0002048588 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,041 F1 · kind: Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025. F2 · price: The weighted average sale price for the transaction reported was $21.126480 and the range of prices were between $21.00 and $21.2933. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.